Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the recipient of a large growth in short interest in June. As of June 30th, there was short interest totalling 732,800 shares, a growth of 165.2% from the June 15th total of 276,300 shares. Approximately 5.2% of the company’s stock are short sold. Based on an […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 276,300 shares, a growth of 36.5% from the May 31st total of 202,400 shares. Currently, 2.0% of the company’s shares are sold short. Based on an average […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 202,400 shares, an increase of 149.9% from the May 15th total of 81,000 shares. Based on an average daily volume of 90,000 shares, the […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target raised by Cantor Fitzgerald from $11.00 to $16.00 in a research report report published on Thursday, The Fly reports. Other research analysts have also issued reports about the company. Citigroup dropped their price target on Longboard Pharmaceuticals from $24.00 to $17.00 and set a buy […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) had its price target increased by Cantor Fitzgerald from $11.00 to $16.00 in a report published on Thursday, The Fly reports. A number of other research firms have also weighed in on LBPH. HC Wainwright reiterated a buy rating and issued a $25.00 price objective on shares of Longboard […]